A Covid-19 vaccine in development by Oxford University in the UK is encouraging.
A study published today in the medical journal @TheLancet reports it has produced a strong immune response in an early-stage human trial of 1,077 people.
(The UK has ordered 100M doses already.)

— Rick Westhead (@rwesthead) July 20, 2020